STOCK TITAN

UBS AG SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UBS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UBS's regulatory disclosures and financial reporting.

Rhea-AI Summary

UBS AG (preliminary pricing supplement) offers Capped Leveraged Buffered S&P 500® Index-Linked medium-term notes with a face amount of $1,000 per note and a term expected to be 25 to 28 months. The notes pay no interest and provide 140.00% upside participation on positive S&P 500 returns subject to a cap (cap level expected between 117.95% and 121.11% of the initial level) and a maximum settlement amount (expected between $1,251.30 and $1,295.54 per $1,000). A buffer protects declines up to 12.50% (buffer level = 87.50% of initial level); below that buffer you lose approximately 1.1429% of face amount for every 1% decline below the buffer. The estimated initial value on the trade date is expected to be between $967.50 and $997.50 per $1,000, which is lower than the issue price. Payments depend on UBS creditworthiness and final terms to be set on the trade date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Contingent Income Auto-Callable Securities linked to the common stock of CVS Health Corporation, expected to price on May 29, 2026 with an original issue date of June 3, 2026 and a maturity date around June 1, 2029. Each security has a $1,000 stated principal amount and may pay a contingent payment of $25.625 (equivalent to 10.25% per annum) on specified determination dates if the closing price of CVS is at or above 65.00% of the initial price. The securities are unsecured obligations of UBS AG, do not guarantee return of principal, do not participate in stock appreciation, and pay cash at maturity if the final price is below the downside threshold. The issue price exceeds the estimated initial value, which UBS estimates between $936.30 and $966.30 as of the pricing date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Filing
Rhea-AI Summary

UBS AG is offering $47,000,350 of Trigger Callable Contingent Yield Notes linked to the least performing of the Russell 2000®, S&P 500® and EURO STOXX 50® indices. The Notes pay quarterly contingent coupons only if each index stays at or above its coupon barrier on every trading day in an observation period, are issuer-callable quarterly at UBS’ election, mature on November 23, 2029, and return principal at maturity only if each final index level is at or above its respective 60% downside threshold; otherwise repayment at maturity will be reduced in proportion to the negative return of the least performing index.

The Notes are offered at $10 per Note (minimum 100 Notes), have an estimated initial value of $9.90, and are unsecured obligations of UBS, so all payments depend on UBS’ creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the least performing of the VanEck® Gold Miners ETF (GDX) and the Nasdaq-100® Technology Sector (NDXT). The offering aggregates $7,102,000 at an issue price of $1,000.00 per Note with an estimated initial value of $960.60. The Notes pay a 15.05% per annum contingent coupon when both underlyings meet their coupon barriers on observation dates, are callable monthly beginning after six months, and mature on May 24, 2029. If not called and any final level is below its downside threshold (60.00% of initial), repayment may be reduced pro rata to the loss of the least performing underlying asset, potentially resulting in a total loss of principal. All payments are subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers $7,000,000 of Step Down Trigger Autocallable Notes maturing May 23, 2031. The Notes are unsecured obligations linked to the least performing of the Russell 2000® Index and the EURO STOXX 50® Index and pay a call return if both indices meet their call threshold on an observation date. Each Note has a $1,000 principal amount, an initial estimated value of $964.40 and an issue price of $1,000. If not automatically called, principal repayment at maturity is contingent: full principal is returned only if both final index levels are at or above their downside thresholds (75.00% of initial levels); otherwise the maturity payment equals $1,000 × (1 + underlying return of the least performing underlying asset), which can result in the loss of a significant portion or all of principal. Payments depend on UBS’ creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $3,792,000 of Trigger Autocallable Contingent Yield Notes linked to the least performing of the Nasdaq-100® Technology Sector (NDXT) and the Russell 2000® Index (RTY). The Notes pay a contingent coupon (8.65% per annum) only if both underlyings meet coupon barriers on monthly observation dates and are callable monthly beginning after six months. If not called and any underlying is below its 70.00% downside threshold at final valuation, principal repayment is reduced pro rata to the decline of the least performing underlying; in extreme cases investors can lose their entire investment. The issue price is $1,000 per Note, the estimated initial value is $964.30, proceeds to UBS are $3,697,200, and the Notes are unsecured obligations subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering $4,420,000 of Trigger Callable Contingent Yield Notes linked to the least performing of the Russell 2000® Index and the Nasdaq-100® Technology Sector. The Notes pay a contingent coupon of 12.80% per annum only if each underlying's closing level on an observation date meets its coupon barrier. UBS may call the Notes monthly beginning after approximately three months; if called you receive principal plus any contingent coupon due on the call settlement date. If not called and the final level of any underlying is below its downside threshold (70% of initial level), repayment may be reduced in proportion to the decline of the least performing underlying, potentially resulting in loss of a significant portion or all of principal. The estimated initial value was $989.00 per $1,000 Note. All payments, including principal, are subject to UBS creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers preliminary pricing for Trigger Callable Contingent Yield Notes linked to the least performing of the Nasdaq-100 Technology Sector (NDXT), the Russell 2000 Index (RTY) and shares of the State Street Utilities Select Sector SPDR ETF (XLU), due on or about June 3, 2030.

The notes pay a contingent coupon only if each underlying meets its coupon barrier on observation dates; the illustrative contingent coupon rate is 10.85% per annum. Issue price is $1,000.00 per Note; estimated initial value is between $953.10 and $983.10; underwriting discount up to $9.50 and per-Note proceeds to UBS at least $990.50. Terms are preliminary and final terms will be set on the strike date when the final pricing supplement is delivered.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering Trigger Callable Contingent Yield Notes with Daily Coupon Observation linked to the least performing of the Nikkei 225®, Russell 2000® and S&P 500®. The Notes have a principal amount of $10 per Note, a contingent coupon rate of 16.80% per annum (contingent), a trade date of May 21, 2026, expected settlement on May 26, 2026, a final valuation date of February 21, 2030 and a maturity date of February 25, 2030. UBS may call the Notes in whole on quarterly observation end dates; if not called, repayment at maturity is contingent: full principal is payable only if each underlying asset’s final level is ≥ its downside threshold (70% coupon barrier; 60% downside threshold shown as percentages of initial levels). Minimum investment is 100 Notes ($1,000). The issuer’s estimated initial value per Note is between $9.585 and $9.885, and all payments are subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the least performing of the Russell 2000® and the S&P 500®. The Notes pay periodic contingent coupons only if both indices meet coupon barriers on observation dates, are callable on quarterly observation dates beginning after six months, and repay principal at maturity only if both indices are at or above the downside thresholds; otherwise repayment is reduced pro rata to the decline of the least performing underlying asset. The Notes carry issuer credit risk, limited upside (coupon-only), potential for large principal loss (including full loss), limited secondary market liquidity, and an estimated initial value below the $10 issue price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many UBS (AMUB) SEC filings are available on StockTitan?

StockTitan tracks 8006 SEC filings for UBS (AMUB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UBS (AMUB)?

The most recent SEC filing for UBS (AMUB) was filed on May 21, 2026.